Champions Oncology (CSBR) Treasury Shares (2011 - 2026)
Champions Oncology (CSBR) posted quarterly Treasury Shares of $708000.0 for Q2 2026, little changed year-over-year from $708000.0 in Q2 2025, and little changed quarter-over-quarter from $708000.0 in Q1 2026.
Champions Oncology (CSBR) Treasury Shares (2011 - 2026) Analysis & Trends
Champions Oncology's Treasury Shares history runs 12 years deep, the most recent figure standing at $708000.0 for Q2 2026.
- In Q2 2026, Treasury Shares changed 0.0% year-over-year to $708000.0; the TTM figure through Apr 2026 stood at $708000.0 (changed 0.0% YoY), while the FY2026 annual figure was $708000.0, changed 0.0% from the prior year.
- Treasury Shares for Q2 2026 stood at $708000.0, roughly flat from $708000.0 in the prior quarter.
- The five-year high for Treasury Shares was $120333.0 in Q4 2023, with the low at $14422.0 in Q2 2023.
- The 4-year median for Treasury Shares is $120333.0 (2023), against an average of $111809.4.
- Peak annual rise in Treasury Shares reached 856.76% in 2024, while the deepest fall reached 0.0% in 2024.
- Champions Oncology's Treasury Shares stood at $708000.0 in 2023, then changed by 0.0% to $708000.0 in 2024, then changed by 0.0% to $708000.0 in 2025, then changed by 0.0% to $708000.0 in 2026.
- Business Quant data shows CSBR's Treasury Shares at $708000.0 in Q2 2026, $708000.0 in Q1 2026, and $708000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.72 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 8.96 Mn |
| 10 | Champions Oncology | 71.17 Mn | 71.17 Mn | 7.03 Mn | 120,333.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 708,000.00 |
| Apr 30, 2026 | 120,333.00 |
| Apr 30, 2026 | 120,333.00 |
| Apr 30, 2026 | 708,000.00 |
| Jan 31, 2026 | 120,333.00 |
| Jan 31, 2026 | 708,000.00 |
| Jan 31, 2026 | 708,000.00 |
| Jan 31, 2026 | 120,333.00 |
| Oct 31, 2025 | 708,000.00 |
| Oct 31, 2025 | 120,333.00 |
| Oct 31, 2025 | 120,333.00 |
| Oct 31, 2025 | 708,000.00 |
| Jul 31, 2025 | 120,333.00 |
| Jul 31, 2025 | 708,000.00 |
| Jul 31, 2025 | 708,000.00 |
| Jul 31, 2025 | 120,333.00 |
| Apr 30, 2025 | 120,333.00 |
| Apr 30, 2025 | 120,333.00 |
| Apr 30, 2025 | 708,000.00 |
| Apr 30, 2025 | 708,000.00 |